Sierra Health Services - SWOT Analysis - SWOT Analysis

Sierra Health Services - SWOT Analysis - SWOT Analysis
  • Report price : $ 125
  • Publication date : October 2008
  • Length : 17 pages

Get this Report Now !

Sierra Health Services - SWOT Analysis - SWOT Analysis

Datamonitor's Sierra Health Services - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Sierra Health Services (SHS), acquired by UnitedHealth Group in February 2008, is a diversified healthcare services company operating health maintenance organizations, indemnity insurers, preferred provider organizations, prescription drug plans and a multi-specialty medical group. Its subsidiaries serve over 860,000 people through health benefit plans for employers, government programs and individuals in the US. The company primarily operates in the US. SHS is headquartered in Las Vegas, Nevada and employs about 3,000 people. The company recorded revenues of $1,909.7 million during the financial year (FY) ended December 2007, an increase of 11.1% over 2006. This increase resulted from an increase in medical premiums, commercial membership and professional fees during the year. The operating profit of the company was $148.7 million during FY2007, a decrease of 31.6% over 2006. The net profit was $94.1 million in FY2007, a decrease of 33% over 2006.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available

RELATED REPORTS

The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities

The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities

  • $ 4 794
  • October 2008
  • 170 pages

The Dermatology Market Outlook to 2013Competitive landscape, pipeline analysis and growth opportunitiesThe dermatology market remains highly competitive, with developers ranging from Big Pharma to biotechnology and specialty pharmaceutical firms. In recent years levels of innovation in the area have ...

Industries : Pharmaceutical

Market Research of Diabetes and its Treatment Medicine-Insulin in China, 2008

Market Research of Diabetes and its Treatment Medicine-Insulin in China, 2008

  • $ 1 880
  • September 2008
  • 50 pages

According to IMS statistics, in 2007 the scale of global anti-diabetes drug market was $24.1 billion, up 13.7 per cent year-on-year, ranking No.5 of the global pharmaceutical market and is expected to have 15 to 20 per cent growth in the future. According to the International Diabetes Federation (I ...

Industries : Pharmaceutical

UK OTC Pharmaceuticals & POM 2008

UK OTC Pharmaceuticals & POM 2008

  • $ 600
  • September 2008
  • 13 pages

Snapdata's Snapshots UK OTC Pharmaceuticals & POM 2008 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the UK otc pharmaceuticals and pom market and covers cardiovascular, central nerv ...

Industries : Pharmaceutical

UK Pharmaceuticals 2008

UK Pharmaceuticals 2008

  • $ 600
  • September 2008
  • 14 pages

Snapdata's Snapshots UK Pharmaceuticals 2008 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the UK pharmaceutical market and covers direct and indirect sales of cardiovascular, centra ...

Industries : Pharmaceutical

UK Analgesics 2008

UK Analgesics 2008

  • $ 600
  • September 2008
  • 13 pages

Snapdata's Snapshots UK Analgesics 2008 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the UK analgesic market and covers non-prescription adult oral analgesics, paediatric analgesics ...

Industries : Pharmaceutical

FHC Health Systems - SWOT Analysis - SWOT Analysis

FHC Health Systems - SWOT Analysis - SWOT Analysis

  • $ 125
  • October 2008
  • 20 pages

Datamonitor's FHC Health Systems, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and stra ...

Industries : Pharmaceutical

Purdue Pharma - SWOT Analysis - SWOT Analysis

Purdue Pharma - SWOT Analysis - SWOT Analysis

  • $ 125
  • October 2008
  • 15 pages

Datamonitor's Purdue Pharma L.P. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. ...

Industries : Pharmaceutical

Nabi Biopharmaceuticals - SWOT Analysis - SWOT Analysis

Nabi Biopharmaceuticals - SWOT Analysis - SWOT Analysis

  • $ 125
  • October 2008
  • 21 pages

Datamonitor's Nabi Biopharmaceuticals - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strat ...

Industries : Pharmaceutical

Roche Holding Ltd - SWOT Analysis - SWOT Analysis

Roche Holding Ltd - SWOT Analysis - SWOT Analysis

  • $ 125
  • October 2008
  • 36 pages

Datamonitor's Roche Holding Ltd. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. ...

Industries : Pharmaceutical

NeoPharm, Inc. - SWOT Analysis - SWOT Analysis

NeoPharm, Inc. - SWOT Analysis - SWOT Analysis

  • $ 125
  • October 2008
  • 22 pages

Datamonitor's NeoPharm, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. NeoP ...

Industries : Pharmaceutical

24/7 Customer Service

Contact Shadi now !

Related industries

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.